Lymphocyte antigen 6E (LY6E), also referred to as RIG-E, SCA2, and TSA1, is a cell surface protein anchored by GPI. It plays a crucial role in regulating the proliferation, differentiation, and activation of T-lymphocytes. LY6E interacts with CD3Z/CD247, a component of the T-cell receptor (TCR) signaling pathway, at the plasma membrane, thereby modulating the phosphorylation of CD3Z/CD247. This interaction restricts the entry of various human coronaviruses, including SARS-CoV, MERS-CoV, and SARS-CoV-2, by interfering with spike protein-mediated membrane fusion. Additionally, LY6E acts as the primary receptor for syncytin-A (SynA), contributing to the normal fusion of syncytiotrophoblast layer I (SynT-I) and the proper development of both fetal and maternal vasculatures within the placenta. It may also function as a modulator of nicotinic acetylcholine receptors (nAChRs) activity.